Online psychosocial support for pregnant women after a fetal anomaly diagnosis

Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly: Randomised Controlled Trial

Not applicable Interventional Sakarya University · NCT07084103

This study tests an online psychosocial support program to help pregnant women told their fetus may have an anomaly cope and protect their mental health.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment64 (estimated)
Ages18 Years and up
SexFemale
SponsorSakarya University Academic / other
Locations1 site (Sakarya, Türkiye/Sakarya)
Trial IDNCT07084103 on ClinicalTrials.gov

What this trial studies

The project begins with qualitative interviews to identify the specific psychosocial support needs of pregnant women carrying fetuses at risk of anomaly, then uses those findings to develop a structured online support program. In a randomized controlled design, eligible women who choose to continue their pregnancy and have high-risk screening or ultrasound findings are assigned to the online program or to routine care. Mental health, coping, and quality-of-life outcomes will be measured with standardized tools to compare the groups. The trial is led by Sakarya University in Türkiye and delivered remotely through online modules.

Who should consider this trial

Good fit: Ideal candidates are pregnant women over age 18 with a high-risk dual/triple screening result or ultrasound findings suggesting fetal anomaly, who have decided to continue the pregnancy, have had at least one hospital visit after diagnosis, can communicate without major psychiatric disorders, and can use online services.

Not a fit: Women planning termination, those under 18, those with conditions that prevent expressing themselves, those without internet access, or anyone who does not meet the study's inclusion criteria are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, the intervention could reduce anxiety and improve coping and quality of life for pregnant women facing a fetal anomaly diagnosis.

How similar studies have performed: Prior in-person psychosocial interventions for prenatal anomaly diagnoses have shown reductions in distress, and early studies of online perinatal support programs have shown promising but mixed results.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* In her current pregnancy, the results of the dual or triple screening test (a screening test result of 1:50 or 1:100 is considered a high risk for Down syndrome (Şirin, 2020) and/or ultrasound findings (physical/anatomical and congenital anomalies) indicate a high risk of foetal abnormalities,
* Decision to continue the pregnancy,
* Being over 18 years of age,
* Having received hospital services at least once after the initial diagnosis (this criterion was added to enable the pregnant woman to evaluate the services she received from the hospital after the diagnosis and to express her expectations beyond the services provided)
* No mental or psychological disorders that would make it difficult to express oneself,
* Voluntary participation in the study.

Exclusion Criteria:

• Pregnant women who do not meet the inclusion criteria will be excluded from the sample.

Where this trial is running

Sakarya, Türkiye/Sakarya

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Fetal DiseasesCongenital AbnormalitiesPregnant WomenPsychosocial Support SystemsMental HealthFetal anomalyCongenital abnormalitiesPsychosocial support
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.